These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25420801)
1. Impact of human leukocyte antigen molecules E, F, and G on the outcome of transplantation. Pabón MA; Navarro CE; Osorio JC; Gómez N; Moreno JP; Donado AF; Pérez HC; Lozano E Transplant Proc; 2014 Nov; 46(9):2957-65. PubMed ID: 25420801 [TBL] [Abstract][Full Text] [Related]
2. HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients. Mossallam GI; Fattah RA; El-Haddad A; Mahmoud HK Hum Immunol; 2015 Mar; 76(2-3):161-5. PubMed ID: 25543014 [TBL] [Abstract][Full Text] [Related]
3. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance. Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652 [TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. Créput C; Durrbach A; Menier C; Guettier C; Samuel D; Dausset J; Charpentier B; Carosella ED; Rouas-Freiss N J Hepatol; 2003 Oct; 39(4):587-94. PubMed ID: 12971970 [TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients. Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563 [TBL] [Abstract][Full Text] [Related]
6. Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients. Žilinská Z; Bandžuchová H; Chrastina M; Trebatický B; Breza J; Handzušová M; Kuba D; Tirpáková J; Pavlechová M; Dedinská I; Rychlý B; Poláková K Transpl Immunol; 2015 Nov; 33(3):159-65. PubMed ID: 26455418 [TBL] [Abstract][Full Text] [Related]
8. Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes. Littera R; Piredda G; Pani A; Frongia M; Onano B; Michittu MB; Murgia MG; Lai S; Alba F; Valentini MD; Loi V; Caocci G; Orrù S; La Nasa G; Carcassi C J Nephrol; 2013; 26(6):1170-8. PubMed ID: 23475463 [TBL] [Abstract][Full Text] [Related]
9. HLA-G14bp ins/del polymorphism and post-transplant weight gain in kidney transplantation: potential implications beyond tolerance. Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; Clemente K; Iesari S; Lai Q; Pisani F BMC Nephrol; 2020 Mar; 21(1):109. PubMed ID: 32228494 [TBL] [Abstract][Full Text] [Related]
10. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149 [TBL] [Abstract][Full Text] [Related]
11. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation. Hosseini E; Schwarer AP; Ghasemzadeh M Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472 [TBL] [Abstract][Full Text] [Related]
12. 14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation. Thude H; Janssen M; Sterneck M; Nashan B; Koch M Hum Immunol; 2016 Dec; 77(12):1159-1165. PubMed ID: 27664842 [TBL] [Abstract][Full Text] [Related]
13. Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival. Guberina H; Rebmann V; Wagner B; da Silva Nardi F; Dziallas P; Dolff S; Bienholz A; Wohlschlaeger J; Bankfalvi A; Heinemann FM; Witzke O; Zoet YM; Claas FH; Horn PA; Kribben A; Doxiadis II Immunobiology; 2017 Mar; 222(3):536-543. PubMed ID: 27871782 [TBL] [Abstract][Full Text] [Related]
14. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens. Puppo F; Brenci S; Contini P; Bignardi D; Hamby CV; Filaci G; Ghio M; Scudeletti M; Picciotto A; Indiveri F; Ferrone S Tissue Antigens; 2000 Apr; 55(4):333-41. PubMed ID: 10852385 [TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124 [TBL] [Abstract][Full Text] [Related]
16. HLA-G gene expression influenced at allelic level in association with end stage renal disease and acute allograft rejection. Misra MK; Pandey SK; Kapoor R; Sharma RK; Kapoor R; Prakash S; Agrawal S Hum Immunol; 2014 Aug; 75(8):833-9. PubMed ID: 24929145 [TBL] [Abstract][Full Text] [Related]
17. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China. Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489 [TBL] [Abstract][Full Text] [Related]
18. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [TBL] [Abstract][Full Text] [Related]
19. HLA-G and humanized mouse models as a novel therapeutic approach in transplantation. Ajith A; Portik-Dobos V; Horuzsko DD; Kapoor R; Mulloy LL; Horuzsko A Hum Immunol; 2020 Apr; 81(4):178-185. PubMed ID: 32093884 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]